Mammalian Target of Rapamycin as the Therapeutic Target of Vascular Proliferative Diseases: Past, Present, and Future

In this study, we discuss mTOR inhibitors as promising candidates to prevent VSMC-associated vascular proliferative diseases.
Source: Journal of Cardiovascular Pharmacology - Category: Cardiology Tags: Review Article Source Type: research